Effect of once weekly dulaglutide by baseline beta-cell function in people with type 2 diabetes in the AWARD programme-Reference-Cited by-同舟云学术

Effect of once weekly dulaglutide by baseline beta-cell function in people with type 2 diabetes in the AWARD programme

Published:2018-05-02 Issue:8 Volume:20 Page:2023-2028
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Mathieu Chantal¹^ORCID,Del Prato Stefano²^ORCID,Botros Fady T.³,Thieu Vivian T.³,Pavo Imre⁴,Jia Nan³,Haupt Axel³^ORCID,Karanikas Chrisanthi A.³,García-Pérez Luis-Emilio³^ORCID

Affiliation:

1. Clinical and Experimental Endocrinology; University of Leuven; Leuven Belgium

2. Department of Clinical and Experimental Medicine, University of Pisa; Pisa Italy

3. Lilly Diabetes; Eli Lilly and Company; Indianapolis Indiana

4. Eli Lilly Regional Operations; Vienna Austria

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13313/fullpdf

Reference24 articles.

1. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes;Kahn;Diabetologia,2003

2. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy;Kahn;N Engl J Med,2006

3. β-cell dysfunction: its critical role in prevention and management of type 2 diabetes;Saisho;World J Diabetes,2015

4. Improving glycaemic control in type 2 diabetes: stimulate insulin secretion or provide beta-cell rest?;Raalte;Diabetes Obes Metab,2017

5. Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists;Madsbad;Diabetes Obes Metab,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes;Diabetologia;2024-02-22

2. Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review;Communications Medicine;2023-10-05

3. Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors;2023-04-22

4. Effect of dulaglutide and long-acting insulin combination therapy in patients with type 2 diabetes: a retrospective observational study;Diabetology International;2022-07-13

5. C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective;Diabetes, Obesity and Metabolism;2022-06-28